Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)

NCT03026842 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Decitabine
DRUG: Daunorubicin, Cytarabine
DRUG: Mitoxantrone, Cytarabine
DRUG: Aclacinomycin, Cytarabine

Sponsor

The First Hospital of Jilin University

Collaborators

[object Object]
[object Object]
[object Object]